With the continuous development of anti-tumor treatment methods, interstitial lung disease (ILD), as one of its common adverse reactions, has gradually attracted widespread clinical attention. In order to further improve the awareness and management level of medical workers regarding tumor associated ILD, the ILD Special Committee of Chengdu High tech Medical Association successfully held the "Tumor Related Adverse Reaction Lecture Hall - Tumor Associated ILD Special Session" online on June 19, 2025. The conference invited several well-known experts to participate in case sharing and discussion. Representatives attending the conference expressed that they have benefited greatly.